Ceftazidime Sodium In Plastic Container

   
Google
 
Web NewDrugInformation.com

Ceftazidime Sodium In Plastic Container


Drug - Ceftazidime Sodium In Plastic Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ceftazidime Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 40MG BASE/ML
The potency of the active ingredient(s), Ceftazidime Sodium. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Ceftazidime Sodium In Plastic Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 063221
The FDA assigned number to Ceftazidime Sodium In Plastic Container. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Ceftazidime Sodium In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 29, 1993
The date Ceftazidime Sodium In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ceftazidime Sodium In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ceftazidime Sodium In Plastic Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp
The full name of the firm holding legal responsibility for the new application of Ceftazidime Sodium In Plastic Container.

Ceftazidime Sodium In Plastic Container